Immunovant logo
Immunovant IMVT
$ 29.26 -3.05%

Quarterly report 2024-Q2
added 08-06-2024

report update icon

Immunovant Operating Cash Flow 2011-2024 | IMVT

Annual Operating Cash Flow Immunovant

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-214 M -188 M -106 M -83.3 M -53.4 M -28.5 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-28.5 M -214 M -112 M

Quarterly Operating Cash Flow Immunovant

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-76.2 M - - - -47.4 M - - -132 M -65.8 M - - -73.2 M -41.3 M - - -60.8 M -38 M - - - -8.33 M -450 - -15.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-450 -132 M -50.8 M